The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to procure the GenePrint® 24 System, which includes 400 reaction kits. This presolicitation opportunity is focused on acquiring in-vitro diagnostic substances, which are critical for various medical and research applications. The procurement will take place in Bethesda, Maryland, and interested vendors can reach out to Tasha Lowe at lowet2@mail.nih.gov or by phone at 301-402-6147 for further details. The timeline for this opportunity and additional funding specifics will be outlined in subsequent announcements.